ArticleLasers in medical science2025
Photobiomodulation associated to a 58S bioactive glass for dentin hypersensitivity treatment - an in vitro study on differentiation of human dental pulp cells.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
To analyze the effects of a 58S experimental bioactive glass associated or not to photobiomodulation (PBM) therapy on the functional differentiation of human dental pulp cells (HDPCs). Dentin discs (1 mm-thick) were mounted on metallic devices, simulating the dental pulp chamber, positioned over HDPC cultures, and the following treatments were applied to the dentin discs, associated or not to PBM (InGaAlP - 660 nm, 5 J/cm², continuous mode, punctual and in contact): BGP - experimental bioactive glass paste; NP - Nupro prophylaxis paste; CXT - Clinpro XT varnish; -control (α-MEM); and +control (Differentiation Medium - DM). After 7, 14 and 21 days, calcium deposition was assessed by the Alizarin Red S staining assay, followed by elution and quantification of calcium, using spectrophotometry. RT-qPCR was used to assess the gene expression for BGLAP, SPP-1, DMP-1, DSPP and IBSP in the negative and positive control, BGP and BGP + PBM groups after 3 days. Data were statistically analyzed (α = 0.05). No significant differences between the experimental groups were found (p = 0.397) at 7 days. BGP group showed greater mineralization potential, differing from α-MEM (p < 0.05), but not from the other groups at 14 days. After 21 days, the BGP, DM, BGP + PBM and CXT groups showed higher mineralization potential, with no significant differences. Regarding gene expression, no significant differences were found for any of the targets tested. The experimental bioactive glass paste and Clinpro XT varnish showed potential for the formation of mineralized nodules after 14 and 21 days, regardless of photobiomodulation.
Indexed as
Identifiers
41003792What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.